Methes Energies International (MEIL) 10-K 25 Feb 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Nov. 30, 2013	Feb. 20, 2014	31-May-13
Document And Entity Information	'	'	'
Entity Registrant Name	'METHES ENERGIES INTERNATIONAL LTD	'	'
Entity Central Index Key	'0001436549	'	'
Document Type	'10-K	'	'
Document Period End Date	30-Nov-13	'	'
Amendment Flag	'false	'	'
Current Fiscal Year End Date	'--11-30	'	'
Is Entity a Well-known Seasoned Issuer?	'No	'	'
Is Entity a Voluntary Filer?	'No	'	'
Is Entity's Reporting Status Current?	'Yes	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Public Float	'	'	$16,262,447
Entity Common Stock, Shares Outstanding	'	8,372,266	'
Document Fiscal Period Focus	'FY	'	'
Document Fiscal Year Focus	'2013	'	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Nov. 30, 2013	Nov. 30, 2012
ASSETS	'	'
Cash and cash equivalents	$174,084	$402,724
Accounts receivable, net	1,154,916	303,418
Inventories	801,063	1,196,798
Prepaid expenses and deposits	84,990	100,972
Deferred financing fees	49,139	26,334
Total current assets	2,264,192	2,030,246
Deposits and employee loans	30,398	13,813
Property, plant and equipment, net	8,178,694	8,231,826
Intangible assets, net	393,015	413,027
Total assets	10,866,300	10,688,912
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'
Credit facility	1,019,513	'
Accounts payable and accrued liabilities	2,977,957	1,762,666
Customer deposits	8,185	'
Short-term loans	1,961,651	1,509,600
Payable to related parties and others	2,251,402	1,617,999
Total liabilities	8,218,708	4,890,265
Stockholders' equity	'	'
Preferred stock, $0.001 par value, 10,000,000 shares authorized; Nil and 260,782 shares issued or outstanding as at November 30, 2012 and 2013, respectively	261	'
Common stock, $0.001 par value, 75,000,000 shares authorized; 6,553,169 and 7,231,417 shares issued and outstanding at November 30, 2012 and 2013, respectively	7,231	6,553
Additional paid-in capital	18,532,803	16,033,123
Accumulated deficit	-15,892,703	-10,241,029
Total stockholders' equity	2,647,592	5,798,647
Total liabilities and stockholders' equity	$10,866,300	$10,688,912

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Nov. 30, 2013	Nov. 30, 2012
Stockholders' equity	'	'
Preferred stock par value	$0.00	$0.00
Preferred stock shares authorized	10,000,000	10,000,000
Preferred stock shares issued	260,782	0
Preferred stock shares outstanding	260,782	0
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	7,231,417	6,553,169
Common stock, shares outstanding	7,231,417	6,553,169

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Revenue	'	'
Biodiesel sales	$7,793,420	$5,801,146
Feedstock sales	320,585	393,208
Glycerin sales	111,507	49,894
Government incentives	547,046	299,540
Equipment sales	7,567	-241,342
Royalties	33,045	66,445
Others	56,767	180,857
Revenue, Total	8,869,937	6,549,748
Cost of goods sold	8,330,648	6,342,874
Gross profit	539,289	206,874
Operating expenses	'	'
Selling, general and administrative expenses	5,665,778	3,926,627
Loss before interest and taxes	-5,126,489	-3,719,753
Other income (expenses)	'	'
Interest expense	-525,576	-250,146
Interest income	400	3,134
Loss before income taxes	-5,651,665	-3,966,765
Income taxes	'	'
Net loss for the period	($5,651,665)	($3,966,765)
Net Loss Per Common Share - Basic and Diluted	($0.82)	($0.67)
Weighted average number of common shares - Basic and Diluted	6,904,706	5,961,659

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)	Common Stock	Preferred Stock	Additional Paid-In Capital	Subscription Receivable	Accumulated Deficit	Total
Beginning Balance, Amount at Nov. 30, 2011	$5,734	'	$11,598,421	($46,056)	($6,274,264)	$5,283,835
Beginning Balance, Shares at Nov. 30, 2011	5,734,447	'	'	'	'	'
Issuance of common stock for cash, Shares	258,722	'	'	'	'	'
Issuance of common stock for cash, Amount	259	'	1,984,792	'	'	1,985,051
Issuance of units - IPO, Shares	560,000	'	'	'	'	'
Issuance of units - IPO, Amount	560	'	2,799,440	'	'	2,800,000
Issuance cost - Common Stock	'	'	-996,477	'	'	-996,477
Stock-based compensation	'	'	246,949	'	'	246,949
Stock subscription	'	'	'	46,056	'	46,056
Penalty shares	'	'	399,998	'	'	399,998
Net loss for the period	'	'	'	'	-3,966,765	-3,966,765
Ending Balance, Amount at Nov. 30, 2012	6,553	'	16,033,123	'	-10,241,029	5,798,647
Ending Balance, Shares at Nov. 30, 2012	6,553,169	'	'	'	'	'
Issuance of units under private placements, Shares	653,248	'	'	'	'	'
Issuance of units under private placements, Amount	653	'	2,149,347	'	'	2,150,000
Issuance cost - Common Stock	'	'	-368,611	'	'	-368,611
Issuance of Common Stock for services, Shares	25,000	'	'	'	'	'
Issuance of Common Stock for services, Amount	25	'	51,975	'	'	52,000
Issuance of preferred stock units under private placement, Shares	'	260,782	'	'	'	'
Issuance of preferred stock units under private placement, Amount	'	261	622,239	'	'	622,500
Issuance cost – preferred shares	'	'	-149,330	'	'	-149,330
Issuance of common stock options to employees and officers	'	'	194,060	'	'	194,060
Dividends payable on preferred stock units	'	'	'	'	-9	-9
Net loss for the period	'	'	'	'	-5,651,665	-5,651,665
Ending Balance, Amount at Nov. 30, 2013	$7,231	$261	$18,532,803	'	($15,892,703)	$2,647,592
Ending Balance, Shares at Nov. 30, 2013	7,231,417	260,782	'	'	'	'

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Cash flow from operating activities:	'	'
Net loss for the period	($5,651,665)	($3,966,765)
Adjustments to reconcile net loss to net cash provided by (used in) operations	'	'
Depreciation and amortization	463,825	258,414
Non-cash stock compensation	194,060	246,949
Unrealized foreign exchange gain (loss)	-120,966	44,700
Penalty share expense	'	399,998
Deferred financing fees	48,388	'
Accrued interest expense	164,306	'
Bad debts	25,970	'
Write-down of processing equipment	115,600	'
Changes in operating assets and liabilities:	'	'
Accounts receivable	-877,468	818,905
Inventories	280,135	-9,356
Prepaid expenses, deposits and employee loans	-603	-87,809
Accounts payable and accrued liabilities	1,215,283	-678,827
Customer deposits	8,185	'
Net cash used in operating activities	-4,134,950	-2,973,791
Cash flows from investing activities:	'	'
Additions to property, plant and equipment	-390,490	-4,657,100
Additions to intangible assets	-192	-30,000
Net cash used in investing activities	-390,682	-4,687,100
Cash flows from financing activities:	'	'
Credit facility	1,019,513	'
Advances of short term loans	1,938,040	1,464,900
Repayment of short-term loans	-1,444,350	'
Advances from related parties and others	692,258	1,097,118
Repayments to related parties and others	-143,835	'
Deferred financing fees	-71,193	-26,334
Issuance of common stock/units, net of issuance costs	1,833,389	3,834,630
Issuance of Preferred Stock/Units, net of issuance costs	473,170	'
Net cash provided by financing activities	4,296,992	6,370,314
NET DECREASE IN CASH AND CASH EQUIVALENTS	-228,640	-1,290,577
Cash and cash equivalents, beginning of period	402,724	1,693,301
CASH AND CASH EQUIVALENTS, END OF PERIOD	174,084	402,724
Supplemental disclosures of cash flow information, cash paid:	'	'
Interest	$361,270	$151,665

1_NATURE_OF_THE_BUSINESS_FINAN

1. NATURE OF THE BUSINESS, FINANCING REQUIREMENTS AND BASIS OF PRESENTATION	12 Months Ended
	Nov. 30, 2013
Accounting Policies [Abstract]	'
1. NATURE OF THE BUSINESS, FINANCING REQUIREMENTS AND BASIS OF PRESENTATION	'
	Methes Energies International Ltd. (the “Company”, or “Methes”) was incorporated on June 27, 2007 in the State of Nevada. Methes, through its operations in Canada and the United States, is a biodiesel processing equipment provider and a biodiesel producer. The Company has developed biodiesel processing equipment to produce biodiesel from recycled oils. The Company, through its wholly-owned subsidiary Methes Energies Canada Inc. (“Methes Canada”), operates two biodiesel manufacturing facilities; one is located in Mississauga, Ontario with a nameplate production capacity of 1.3 million gallons per year (mmgy), and the second facility is capable of producing 13.0 mmgy of biodiesel located in Sombra, Ontario. In addition to Methes Canada, Methes Energies USA Ltd. ("Methes USA") was incorporated as the wholly-owned subsidiary of the Company on June 27, 2007.
	On October 4, 2012, Methes Canada was approved by the U.S. Environmental Protection Agency ("EPA") as a Foreign Renewable Fuel Producer at its Sombra, Ontario plant. As a result the biodiesel produced at its Sombra, Ontario facility also became eligible for export to the United States. Obtaining this approval from the EPA enables the Company to sell its biodiesel produced at its Sombra, Ontario facility into the U.S., and provides its U.S. importer the ability to generate Renewable Identification Numbers ("RINS"). RINS are used in the U.S. by obligated parties to comply with the Renewable Fuel Standard 2 ("RFS2").
	On October 12, 2012, the Company’s registration statement on Form S-1 (File No. 333-182302) for its initial public offering (“IPO”) was declared effective by the U.S. Securities and Exchange Commission (“SEC”).  On October 30, 2012, the Company consummated the IPO pursuant to which it sold 560,000 units (each a “Unit”) at a price of $5.00 per Unit, and received net proceeds of $1.8 million, after deducting the underwriting fees and offering expenses. Each Unit consisted of (i) one share of common stock, $.001 par value (“Common Stock”), (ii) one Class A warrant, to purchase one share of Common Stock at an exercise price of $7.50 (each a “Class A Warrant”), and (iii) one Class B warrant, to purchase one share of Common Stock at an exercise price of $10.00 (each a “Class B Warrant”).
	The Units were listed on the NASDAQ Capital Market under the symbol “MEILU”.  Up to November 26, 2012, only the Units were traded.  On November 26, 2012, the Common Stock and the Warrants began trading separately under the symbols MEIL, MEILW and MEILZ when the Units ceased trading and were delisted.
	As at November 30, 2013, due in large part to the funds spent to develop and build the Sombra facility, the Company had a working capital deficiency of $5,954,516. In order to meet its objectives, the Company required additional financing at November 30, 2013 to get the second machine at Sombra operational and to fund working capital. The Company anticipates that its Sombra facility will generate positive cash flow from operations and will operate profitably once full-scale commercial operations are achieved in the second quarter of fiscal year 2014. It is management’s opinion that the anticipated positive cash flows from operations, cash from additional and refinanced loans along with the proceeds from the subsequent Private Placement referred to in Note 18, will be sufficient to meet the Company’s financing requirements for at least the next 12 months.

2_SUMMARY_OF_SIGNIFICANT_ACCOU

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Nov. 30, 2013
Accounting Policies [Abstract]	'
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	a)	Basis of Presentation
		The consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and are expressed in United States dollars. The Company’s fiscal year-end is November 30.
		The Company is an emerging growth company (EGC) pursuant to Jumpstart Our Business Startups Act of 2012 (the JOBS Act). Under Section 102(b) of the JOBS Act, the Company has elected to apply any new or revised financial accounting standard on the same date a company that is not an issuer is required to apply the new or revised accounting standard, if the standard applies to a non-issuer. If the new or revised accounting standard does not apply to a non-issuer, then the Company will apply it according to the transition provisions for a non-EGC. The Company’s election to use the extended transition period for complying with new or revised accounting standards under Section 102(b) of the JOBS Act had no impact on the consolidated financial statements as of November 30, 2013 and 2012.
	b)	Basis of Consolidation
		The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Methes Canada and Methes USA.  All significant inter-company transactions and balances have been eliminated. Methes Canada was incorporated on December 23, 2004, and became a wholly-owned subsidiary of the Company on September 5, 2007. Methes USA was incorporated as a wholly-owned subsidiary of the Company on June 27, 2007.
	c)	Use of Estimates
		The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Areas involving significant estimates and assumptions include: inventory valuation reserves; allowance for doubtful accounts; deferred income tax liabilities and assets, and related valuation allowances; expected future cash flows used in evaluating intangible assets and property, plant and equipment for impairment; estimated useful life of property, plant and equipment and intangible assets; and valuation of stock options and broker warrants. The estimates and assumptions made require judgment on the part of management and are based on the Company’s historical experience and various other factors that are believed to be reasonable in the circumstances. Management continually evaluates the information that forms the basis of its estimates and assumptions as the business of the Company and the business environment generally changes. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s consolidated financial statements could be materially impacted.
	d)	Cash and Cash Equivalents
		The Company considers all highly liquid investments with a maturity of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents consist primarily of bank deposits held in the United States and Canada.
	e)	Inventories
		The Company’s inventories consist primarily of bulk biodiesel, methanol, catalyst, crude glycerin and biodiesel processing equipment and are valued at the lower of cost and market value, with cost determined on a weighted average basis. Cost for finished goods inventories includes materials, direct labor, and an allocation of overheads. Market for raw materials is replacement cost, and for finished goods is net realizable value.
		The Company evaluates the carrying value of inventories on a regular basis, taking into account such factors as historical and anticipated future sales compared with quantities on hand and the price the Company expects to obtain for products in the market compared with historical cost.
	f)	Allowance for Doubtful Accounts
		The Company establishes an allowance for doubtful accounts based on management’s assessment of the collectability of trade receivables.  A considerable amount of judgment is required in assessing the amount of the allowance.  The Company makes judgments about the creditworthiness of each customer based on ongoing credit evaluations, and monitors current economic trends that might impact the level of credit losses in the future.  If the financial condition of the customers were to deteriorate, resulting in their inability to make payments, a specific allowance will be required. Account balances are charged off against the allowance when the Company believes it is probable the receivable will not be recovered.
	g)	Revenue Recognition
		Revenue is recognized in accordance with ASC 605, "Revenue Recognition in Financial Statements."  Under ASC 605, product or service revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or service has been performed, the sales price is fixed and determinable and collectability is reasonably assured. The Company has not experienced any material expense in satisfying warranties. Details of specific recognition by product or service categories are as follows:
		●	Revenue from the sale of biodiesel and its co-product, biodiesel processing equipment and feedstock is recognized when title and possession of the product is transferred to the customer. Possession is transferred to the customer at the time of shipment from the Company’s facility or at the time of delivery to a specified destination, depending on the terms of the sale.
		●	The ecoENERGY incentive is recognized as revenue when the right to receive is established upon production and sale of biodiesel.
		●	Revenue from services is recognized as services are performed.
		●	Royalty revenue is recognized on an accrual basis in accordance with the Sales & Licensing Agreement of the biodiesel processing equipment sale. Royalty is charged on gallons of biodiesel produced by the Company's customers using the Company’s biodiesel processing equipment.
	h)	Shipping and Handling Costs
		The Company accounts for shipping and handling fees in accordance with FASB ASC 705 “Cost of Sales and Services”. Shipping and handling costs for the years ended November 30, 2012 and 2013 were $344,146 and $309,675, respectively. Costs related to raw materials purchased, are included in inventory or cost of goods sold, as appropriate. While amounts charged to customers for shipping product are included in revenues, the related outbound freight costs are included in expenses as incurred.
	i)	Deferred Financing Fees
		Costs directly incurred in connection with the IPO were recorded as deferred financing fees until the completion of the IPO. These deferred financing fees were charged against additional paid-in capital upon completion of the IPO. Financing fees relating to other financing arrangements are deferred and amortized over the term of the respective loan. Deferred financing fees as at November 30, 2012 and 2013 were $26,334 and $49,139, respectively.
	j)	Financial Instruments
		The Company’s financial instruments recognized in the consolidated balance sheets and included in working capital consist of cash and cash equivalents, accounts receivable, credit facility, accounts payable and accrued liabilities, amounts due to related parties and other,  and short-term loan. The fair values of these instruments approximate their carrying values due to their short-term maturities.
	k)	Fair Value Measurements
		Financial instruments that are measured subsequent to initial recognition at fair value are grouped into hierarchy based on the degree to which the fair value inputs are observable.
		Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., an exit price). Fair value measurements are estimated based on inputs categorized as follows:
		●	Level 1 inputs include quoted prices (unadjusted) for identical assets or liabilities in active markets that are observable.
		●	Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
		●	Level 3 includes unobservable inputs that reflect the Company's own assumptions about what factors market participants would use in pricing the asset or liability.
			When measuring fair value, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs.
	l)	Foreign Currency Translation
		The functional currency of the Company and its subsidiaries is the United States dollar. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction.  Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities are translated using the historical rate on the date of the transaction. Revenue and expenses are translated at average rates in effect during the reporting periods. All exchange gains or losses arising from translation of these foreign currency transactions are included in net income (loss) for the year. The Company has not, to the date of these consolidated financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.
	m)	Income Taxes and Uncertain Tax Positions
		The Company accounts for income taxes under ASC 740 Accounting for Income Taxes. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. ASC 740-10-05, Accounting for Uncertainty in Income Taxes, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return.
		For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
		The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Potential tax benefits from net operating losses and foreign tax credit carry forwards are not recognized by the Company until their realization is more likely than not. We assess the validity of our conclusions regarding uncertain tax positions on a quarterly basis to determine if facts or circumstances have arisen that might cause us to change our judgment regarding the likelihood of a tax position’s sustainability under audit.  The Company has determined that there were no material uncertain tax positions as at November 30, 2012 and 2013.
	n)	Stock-based Compensation
		The Company maintains a stock-based compensation plans under which incentive stock options to buy Common Stock may be granted to directors, officers and employees. Pursuant to ASC 718, the Company recognizes expense for its stock-based compensation based on the fair value of the awards that are granted. The fair values of stock options are estimated at the date of grant using the Black-Scholes option pricing model, that require the input of highly subjective assumptions. Measured compensation cost is recognized ratably over the vesting period of the related stock-based compensation award. The amount recognized as expense is adjusted to reflect the number of stock options expected to vest. When exercised, stock options are settled through the issuance of Common Stock and are therefore treated as equity awards. The expected volatility of our Common Stock is estimated using an average of volatilities of publicly traded companies in similar renewable energy businesses.
	o)	Property, Plant and Equipment
		Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is provided using the straight-line basis at the following annual rates reflecting the estimated useful lives of the assets:
	Sombra facility:
	Building	40 years
	Equipment	5 years
	Equipment - Denami 3000	25 years
	Computer equipment	2 years
	Vehicle	10 years
	Mississauga facility:
	Computer equipment	2 years
	Leasehold improvements	Over the lease term
	Equipment and fixtures	5 years
	Equipment - Denami 600	25 years
	p)	Intangible Assets
		The Company’s finite-lived intangible assets consist of acquired intellectual property from a third party for the design and engineering of Denami 600 and Denami 3000 biodiesel processor equipment.  The intangible assets related to the Denami 600 and Denami 3000 are recorded at cost, less accumulated amortization and the amortization is provided over their 25 year estimated useful life on a straight-line basis.
	q)	Impairment of Long-Lived Assets
		The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amounts of the assets may not be recoverable through undiscounted future cash flows. If impairment exists based on expected future undiscounted cash flows, a loss is recognized in income. The amount of the impairment loss is the excess of the carrying amount of the impaired asset over the fair value of the asset, typically based on discounted future cash flows. The Company has assessed its long-lived assets and has determined that there was no impairment in their carrying amounts at November 30, 2012 and 2013.
	r)	Per Share Data
		Basic earnings per share (“EPS”) is determined by dividing net earnings available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the year. In computing diluted EPS, the average number of shares of Common Stock outstanding is increased by Common Stock options and warrants outstanding if the exercise prices were lower than the average market price of Common Stocks using the treasury stock method. Diluted earnings per share exclude all potentially dilutive shares if their effect is anti-dilutive. Potentially dilutive shares include 1,267,264 warrants and 383,310 Common Stock options issued and outstanding as at November 30, 2012 and 2,678,872 warrants, 260,782 Preferred Stock and 465,931 Common Stock options issued and outstanding as at November 30, 2013. All outstanding warrants, preferred stocks and options have an anti-dilutive effect on the loss per share and are therefore excluded from the determination of the 2012 and 2013 diluted loss per share calculation.
	s)	Recent Accounting Pronouncements
		In September 2011, the FASB issued ASU 2011- 08, Intangibles - Goodwill and Other, which amends ASC Topic 350 and the current guidance on testing goodwill for impairment. Under the revised guidance, entities testing goodwill for impairment have the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit exceeds its carrying amount. If an entity determines it is more likely than not that the fair value of a reporting unit exceeds its carrying amount, then performing the two-step impairment test is unnecessary. The amendments are effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011.   The Company adopted this statement effective December 1, 2012. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements.
		In December 2011, the FASB issued ASU No. 2011-11, Disclosures about Offsetting Assets and Liabilities (Topic 210). The new disclosure requirements mandate that entities disclose both gross and net information about instruments and transactions eligible for offset in the statement of financial position as well as instruments and transactions subject to an agreement similar to a master netting arrangement. In addition, the standard requires disclosure of collateral received and posted in connection with master netting agreements or similar arrangements. The amendments are effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The disclosures required by the amendments are required to be applied retrospectively for all comparative periods presented. The Company does not believe the adoption of this standard will have a material impact on its consolidated financial statements.
All other recent pronouncements issued by the FASB or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the consolidated financial statements of the Company.

3_ACCOUNTS_RECEIVABLE

3. ACCOUNTS RECEIVABLE	12 Months Ended
	Nov. 30, 2013
Receivables [Abstract]	'
3. ACCOUNTS RECEIVABLE	'
	The following schedule provides an analysis of the Company’s accounts receivable:
		As at		As at
		November 30,		November 30,
		2012		2013
	Trade receivables	$	333,418	$	1,184,916
	Allowance for doubtful accounts		-30,000		-30,000
		$	303,418	$	1,154,916

4_INVENTORIES

4. INVENTORIES	12 Months Ended
	Nov. 30, 2013
Inventory Disclosure [Abstract]	'
4. INVENTORIES	'
	Inventories consisted of the following:
			As at		As at
			November 30,		November 30,
			2012		2013
	Raw materials		$	330,627	$	345,049
	Finished goods			739,205		444,648
	Equipment (i)			126,966		11,366
			$	1,196,798	$	801,063
	(i)	During fiscal 2013, certain previously returned oil processing research and development related equipment having a cost of $115,600 was written down and is included in cost of goods sold.

5_PROPERTY_PLANT_AND_EQUIPMENT

5. PROPERTY, PLANT AND EQUIPMENT	12 Months Ended
	Nov. 30, 2013
Property, Plant and Equipment [Abstract]	'
5. PROPERTY, PLANT AND EQUIPMENT	'
		As at November 30, 2012
				Accumulated		Net Book
		Cost		Depreciation		Value
	Sombra site:
	Land	$	409,134	$	-	$	409,134
	Building		2,820,294		168,663		2,651,631
	Equipment		727,020		257,475		469,545
	Equipment - Denami 3000		3,964,293		25,059		3,939,234
	Mississauga site:
	Computer equipment		30,014		20,589		9,425
	Leasehold improvements		102,202		45,218		56,984
	Equipment and fixtures		255,463		146,782		108,681
	Equipment - Denami 600		720,042		132,850		587,192
		$	9,028,462	$	796,636	$	8,231,826
		As at November 30, 2013
				Accumulated		Net Book
		Cost		Depreciation		Value
	Sombra site:
	Land	$	409,134	$	-	$	409,134
	Building		2,944,356		241,910		2,702,446
	Equipment		775,865		385,400		390,465
	Equipment - Denami 3000		4,164,968		189,527		3,975,441
	Computer equipment		11,835		5,917		5,918
	Vehicle		11,622		291		11,331
	Mississauga site:
	Computer equipment		23,464		22,148		1,316
	Leasehold improvements		102,201		55,610		46,591
	Equipment and fixtures		255,463		177,801		77,662
	Equipment - Denami 600		720,042		161,652		558,390
		$	9,418,950	$	1,240,256	$	8,178,694
	Total depreciation expense included in selling, general and administrative expenses in the consolidated statements of operations related to property, plant and equipment for the year ended November 30, 2012 and 2013 was $241,083 and $443,619, respectively.

6_INTANGIBLE_ASSETS

6. INTANGIBLE ASSETS	12 Months Ended
	Nov. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
6. INTANGIBLE ASSETS	'
	The major components of finite-lived intangible assets, which consist of acquired intellectual property for the design and engineering of biodiesel processor equipment, were as follows:
		As at November 30, 2012
				Accumulated		Net Book
		Cost		Amortization		Value
	Denami 600	$	414,174	$	91,477	$	322,697
	Denami 3000		90,735		405		90,330
		$	504,909	$	91,882	$	413,027
		As at November 30, 2013
				Accumulated		Net Book
		Cost		Amortization		Value
	Denami 600	$	414,174		108,045	$	306,129
	Denami 3000		90,927		4,041		86,886
		$	505,101	$	112,086	$	393,015
	Total amortization expense included in selling, general and administrative expenses in the consolidated statements of operations related to intangible assets for the year ended November 30, 2012 and 2013 was $17,331and $20,206, respectively.
	Estimated future aggregate amortization expense for fiscal years ending November 30 is as follows:
		2014		2015		2016		2017		2018		Thereafter
	Amortization expense	$	20,202	$	20,202	$	20,202	$	20,202	$	20,202	$	292,005

7_ACCOUNTS_PAYABLE_AND_ACCRUED

7. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	12 Months Ended
	Nov. 30, 2013
Payables and Accruals [Abstract]	'
7. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	'
	Accounts payable and accrued liabilities are comprised of the following:
		As at		As at
		November 30,		November 30,
		2012		2013
	Accounts payable	$	1,128,115	$	2,766,661
	Accrued liabilities		634,551		211,296
		$	1,762,666	$	2,977,957

8_SHORTTERM_LOANS

8. SHORT-TERM LOANS	12 Months Ended
	Nov. 30, 2013
Debt Disclosure [Abstract]	'
8. SHORT TERM LOANS	'
			As at		Advances and Reallocations		Interest Accrued		Repayments		Foreign Exchange Adjustments		As at
			November 30,										November 30,
			2012										2013
	Term loan (June 2012)		$	1,509,600	$	-	$	-	$	-1,444,350	$	-65,250	$	-
	Term loan (July 2013)			-		1,540,640		-		-		-34,080		1,506,560
	Promissory note (i)			-		49,333		3,200		-		-		52,533
	Promissory note (ii)			-		397,400		25,915		-		-20,757		402,558
			$	1,509,600	$	1,987,373	$	29,115	$	-1,444,350	$	-120,087	$	1,961,651
	Term loan (June 2012)
	On June 20, 2012, Methes Canada entered into a term loan facility agreement with a lender that allows Methes Canada to borrow up to $1,412,400 (historical amount of $1,464,900 or CDN$1,500,000). The term loan, which was drawn in late June 2012, was repayable in 12 months and bore interest at 23% per annum. The loan was fully repaid in July 2013 from another term loan entered into on July 12, 2013 discussed below. Interest expense incurred during the year ended November 30, 2012 and 2013 was $149,375 and $212,635, respectively.
	Term loan (July 2013)
	On July 12, 2013, Methes Canada entered into a term loan facility agreement with a lender (the “Agreement”) pursuant to which Methes Canada is able to borrow up to $1,506,560 (historical amount of $1,540,640 or CDN$1,600,000) for a term of 12 months at an interest rate of 12% per annum (the “July 2013 Facility”). Under the terms of the Agreement, interest is payable monthly and outstanding principal is due at maturity. Outstanding principal would be prepayable after six months upon 30 days’ notice and payment of a penalty equal to one-month's interest. The July 2013 Facility is collateralized by a security agreement from Methes Canada on certain of its assets except for accounts receivable and inventory and a first collateral mortgage on its real property located at Sombra, Ontario.  The July 2013 Facility prohibits payment of debt owed by the Company to certain of its stockholders and a director (see note 10) during the life of the facility and contains other customary debt covenants. See note 18, Subsequent Events, for discharging and refinancing of this loan.
	Interest expense incurred during the year ended November 30, 2012 and 2013 was $nil and $70,897, respectively.
	The proceeds from the July 2013 Facility were used to repay the term loan (June 2012) of $1,444,350 (historical amount of $1,464,900 or CDN$1,500,000).
	Promissory Notes:
	(i)	In January 2010, the Company borrowed $40,000 from a lender and issued to the lender a demand promissory note in the principal amount of $40,000 bearing interest of 8% per annum.  Repayment of the loan and payment of the accrued interest is due upon demand. Interest expense incurred during the year ended November 30, 2012 and 2013 was $3,200 and $3,200, respectively.  Previously, this loan was grouped as payable to related party as the lender held stocks of the Company.  As at November 30, 2013, no stocks are held by the lender and therefore, this loan has been regrouped under short-term loans.
	(ii)	On January 26, 2013, the Company borrowed $376,640 (historical amount of $397,400 or CDN $400,000) from a lender and issued to the lender a demand promissory note in the principal amount of CDN $400,000 bearing interest of 8% per annum (the “January 2013 Note”). Repayment of the loan and payment of the accrued interest will be due upon demand. Interest expense incurred during the year ended November 30, 2012 and 2013 was $nil and $25,915, respectively. On January 17, 2014, this note was partially settled through issuance of shares of Common Stock. On January 30, 2014, a part of this note was settled through cash repayment.  See 'Subsequent Events', Note 18.

9_CREDIT_FACILITY

9. CREDIT FACILITY	12 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
9. CREDIT FACILITY	'
	On August 16, 2013, Methes Canada entered into and closed on a working capital loan facility from a Toronto, Ontario lending firm (the “Working Capital Facility”). Under the Working Capital Facility, Methes Canada may borrow up to $1,500,000 for its Sombra, Ontario biodiesel manufacturing plant, of which up to $750,000 may be from cash advances against Methes Canada’s accounts receivables through factoring of accounts receivable with full recourse and up to an additional $750,000 in cash advances for use exclusively to purchase feedstock for the production of biodiesel. The Working Capital Facility is secured by a pledge of the accounts receivable and inventory of Methes Canada and Methes USA.
	In connection with all borrowings to purchase feedstock, Methes Canada issued a promissory note to the lender bearing a per annum interest rate equal to the Bank of Montreal Prime Rate plus sixteen percent (16%) and is due and payable upon the earlier of demand or August 13, 2014. The effective interest rate as of November 30, 2013 was 19% (16% plus 3% prime rate).  Under the terms of the promissory note, interest only is payable monthly on the last business day of each calendar month. Cash advances against accounts receivables will be based on the amount of the receivables net of a purchase discount as agreed with the lender with an interest rate of Bank of Montreal Prime Rate plus three percent (3%).  Effective interest rate as of November 30, 2013 was 6% (3% plus 3% prime rate). The amounts outstanding under this promissory note must be recorded on the grid schedule provided by the lender. As of November 30, 2013 there is a balance of $1,019,513 payable to the lender under the Working Capital Facility (November 30, 2012 - $nil).
	Interest expense incurred for the year ended November 31, 2012 and 2013 was $nil and $65,822, respectively.

10_PAYABLE_TO_RELATED_PARTIES_

10. PAYABLE TO RELATED PARTIES AND OTHERS	12 Months Ended
	Nov. 30, 2013
Related Party Transactions [Abstract]	'
10. PAYABLE TO RELATED PARTIES AND OTHERS	'
	Payable to related parties is comprised of the following:
		As at		As at
		November 30,		November 30,
		2012		2013
	Michel G. Laporte (stockholder and Director)	$	172,389	$	719,230
	World Asset Management Inc. (stockholder)		1,396,277		1,495,477
	Soft Diffusion SA (see note 8 (i))		49,333		-
	Other loan		-		36,695
		$	1,509,600	$	2,251,402
	The payables to related parties and others bear interest at a rate of 8% per annum, are unsecured and repayable on demand.  The related parties and others have agreed in writing to postpone the repayment of their debts in favour of the credit facility referred to in note 9. Interest expense for the year ended November 30, 2013 was $135,191 ($97,118 for the year ended November 30, 2012).

11_INCOME_TAXES

11. INCOME TAXES	12 Months Ended
	Nov. 30, 2013
Income Tax Disclosure [Abstract]	'
11. INCOME TAXES	'
	The following table reconciles the expected income tax recovery at the statutory federal income tax rate of 34% to the amount recognized in the statements of operations:
		Year Ended			Year Ended
		November 30,			November 30,
		2012			2013
	Loss before income taxes	$	3,966,765		$	5,651,665
	Expected income tax recovery		(1,388,368	)		-1,978,080
	Non-deductible expenses		220,364			74,570
	Difference in foreign tax rates, changes in tax rate, foreign exchange impact on translation of tax base and other adjustments		87,315			558,030
	Change in valuation allowance		1,080,689			1,345,480
		$	-		$	-
	The Company’s deferred income tax assets and liabilities, which are primarily related to Canada, are as follows:
		As at			As at
		November 30,			November 30,
		2012			2013
	Deferred income tax assets
	Non-capital losses carried forward	$	2,453,326		$	4,024,820
	Less: allocated against deferred tax liabilities		(405,383	)		-631,390
	Less: valuation allowance		(2,047,943	)		-3,393,430
		$	-		$	-
	Deferred tax liabilities
	Property, plant and equipment and intangible assets	$	405,383		$	631,390
	Less: offset by deferred tax assets		(405,383	)		-631,390
		$	-		$	-
	Since inception to November 30, 2013 the Company has incurred net losses, primarily related to Canada, for tax purposes of $16,211,333, which expire at various times through fiscal 2033. Pursuant to ASC 740, the Company is required to compute tax asset benefits for net operating losses carried forward. However, the potential tax benefit of net operating losses has not been recognized in these consolidated financial statements due to the uncertainty of their realization.
	As at November 30, 2013 and 2012, the Company is not subject to any uncertain tax positions.

12_STOCKHOLDERS_EQUITY

12. STOCKHOLDERS' EQUITY	12 Months Ended
	Nov. 30, 2013
Equity [Abstract]	'
12. STOCKHOLDERS' EQUITY	'
	Common Stock
	The Company is authorized to issue 75,000,000 shares of Common Stock with a par value of $0.001 and had 6,553,169 and 7,231,417 shares of Common Stock issued and outstanding as of November 30, 2012 and 2013, respectively.
			No. of Shares			Price per Share
	Common Stock
	Balance as at November 30, 2011			5,734,447
	Issuance for cash			258,722		$	7.67
	October 2012 – IPO issuance			560,000		$	5
	Balance as at November 30, 2012			6,553,169
	February 2013 Private Placement			425,000		$	4
	August 2013 Private Placement			28,248		$	1.77
	November 2013 Private Placement			200,000		$	2
	November 2013 Issuance			25,000		$	2.08
				7,231,417
	February 2013 Private Placement:
	In the February 2013 Private Placement, the Company issued 425,000 Units to accredited investors at a price of $4.00 per unit and raised net proceeds of approximately $1,493,850, after deducting the sales commission and fees. Each Unit consists of one share of Common Stock, one Class A Warrant and one Class B Warrant, identical to the securities issued under the IPO. Each Class A and Class B warrant is exercisable to purchase one share of Common Stock at $7.50 and $10.00, respectively, and expires on October 12, 2017.
	In connection with the issuance of the Units in the February 2013 Private Placement, the Company issued warrants to purchase an aggregate of 42,500 Units, with an exercise price of $4.20 per Unit, to the placement agents for the February 2013 Private Placement. The fair value of these warrants on the issuance date was $101,600, which has been recorded to additional paid-in capital. This amount was estimated using the Black-Scholes option pricing model with an expected life of 5 years, a risk free interest rate of 0.89%, a dividend yield of 0%, and an expected volatility of 75% (see Stock Warrants table below).
	August 2013 Private Placement:
	In August 2013, the Company raised gross proceeds of $50,000 in the Regulation S Private Placement, pursuant to which it issued 28,248 shares of Common Stock and 28,248 Regulation S Warrants.  Under the Regulation S Private Placement, the Company is authorized to sell, issue and deliver up to 1,000,000 units at a price per unit equal to the closing price per share of Common Stock on the trading day immediately preceding each closing plus $0.125.  Each unit consists of one share of Common Stock and one Regulation S Warrant.
	November 2013 Private Placement:
	In November 2013, the Company commenced a private offering of 1,281,161 common stock units ("Common Stock Units") at $2.00 per unit (the “Common Stock Unit Private Placement”).  Each unit consisted of one share of Common Stock and one five year Common Stock purchase warrant to purchase one share of Common Stock at an exercise price of $4.00 per share, which are exercisable beginning six months after the issuance date (the “Common Stock Warrant”).  In November 2013, the Company sold an aggregate of 200,000 Common Stock Units to accredited investors and raised net proceeds of approximately $363,000, after deducting the sales commission and fees, in the Common Stock Unit Private Placement. (see Note 18 "Subsequent Events” for sale of the remaining Common Stock Units).
	In connection with the issuance of some of the units in the Common Stock Unit Private Placement, the Company issued warrants to purchase an aggregate of 5,000 Common Stock Units, with an exercise price of $2.00 per unit, to the placement agents for the Common Stock Unit Private Placement. The fair value of these warrants on the issuance date was $6,400, which has been recorded to additional paid-in capital. This amount was estimated using the Black-Scholes option pricing model with an expected life of 5 years, a risk free interest rate of 1.36%, a dividend yield of 0%, and an expected volatility of 75%. (Issued December 20, 2013).
	November 2013 Issuance:
	On November 18, 2013, the Company entered into a Consulting Agreement pursuant to which it agreed to issue 100,000 shares of Common Stock in four equal installments to a consultant as payment for services rendered and to be rendered by the consultant to the Company.  The number of shares of Common Stock was determined based on the $2.08 per share closing market price on November 18, 2013.  To date, 25,000 shares of Common Stock have been issued to a consultant pursuant to the Consulting Agreement.
	Preferred Stock
	The Company is authorized to issue 10,000,000 shares of Preferred Stock with a par value of $0.001 and had nil and 260,782 shares of preferred stock issued or outstanding as of November 30, 2012 and 2013.
			No. of Shares			Price per Share
	Preferred Stock
	Balance as at November 30, 2012			-
	Series A-1 Private Placement			138,654		$	2.38
	Series A-2 Private Placement			122,128		$	2.395
				260,782
	Series A-1 Private Placement:
	In September 2013, the Company issued 138,654 units to accredited investors at a price of $2.38 per unit (the “Series A-1 Units”) under its Series A-1 Preferred Stock private placement and raised net proceeds of approximately $251,300, after deducting the sales commission and fees. Each unit consists of one share of Series A 10% Cumulative Convertible Preferred Stock, par value $0.001 per share of the Company (“Series A Preferred Stock”) and one five year Common Stock purchase warrant to purchase one share of Common Stock at an exercise price of $4.00 per share, which are exercisable beginning six months after the issuance date (the “Series A Warrant”).
	In connection with the issuance of the Series A-1 Units, the Company issued warrants to purchase an aggregate of 13,865 Series A-1 Units, with an exercise price of $2.38 per Unit, to the placement agents for the Private Placement. The fair value of these warrants on the issuance date was $10,330, which has been recorded to additional paid-in capital. This amount was estimated using the Black-Scholes option pricing model with an expected life of 5 years, a risk free interest rate of 1.74%, a dividend yield of 10%, and an expected volatility of 75%. (see Stock Warrants table below).
	Series A-2 Private Placement:
	In October 2013, the Company issued 122,128 units to accredited investors at a price of $2.395 per unit (the “Series A-2 Units”) under its Series A-2 Preferred Stock private placement and raised net proceeds of approximately $221,610, after deducting the sales commission and fees. Each unit consists of one share of Series A 10% Cumulative Convertible Preferred Stock, par value $0.001 per share of the Company (“Series A Preferred Stock”) and one five year Common Stock purchase warrant to purchase one share of Common Stock at an exercise price of $4.00 per share, which are exercisable beginning six months after the issuance date (the “Series A Warrant”).
	In connection with the issuance of the Series A-2 Units, the Company issued warrants to purchase an aggregate of 12,213 Series A-2 Units, with an exercise price of $2.395 per Unit, to the placement agents for the Private Placement. The fair value of these warrants on the issuance date was $8,500, which has been recorded to additional paid-in capital. This amount was estimated using the Black-Scholes option pricing model with an expected life of 5 years, a risk free interest rate of 1.29%, a dividend yield of 10%, and an expected volatility of 75%. (see Stock Warrants table below).
	Stock Warrants Table
		Grant Date		Exercise Period	No of Warrants			Exercise Price per share		Fair Value of Broker Warrants
	Balance as at November 30, 2011	Nov. 23, 2011		2 years from October 1, 2013		65,189		$	5
	Warrants issued	Jan. 27, 2012		2 years from October 1, 2013		26,075		$	5
	Class A warrants - IPO related	Oct. 12, 2012		5 years from October 30, 2013		560,000		$	7.5
	Class B warrants - IPO related	Oct. 12, 2012		5 years from October 30, 2013		560,000		$	10
	Broker Warrants related to IPO	Oct. 12, 2012		5 years from October 30, 2013		56,000		$	6	$	159,250
	Class A warrants	Oct. 25, 2012		5 years from October 30, 2013		2,000		$	7.5
	Class B warrants	Oct. 25, 2012		5 years from October 30, 2013		2,000		$	10
	Balance as at November 30, 2012					1,271,264
	Class A warrants - Private Placement	Feb. 19, 2013		5 years from grant date		425,000		$	7.5
	Class B warrants - Private Placement	Feb. 19, 2013		5 years from grant date		425,000		$	10
	Broker warrants - Private Placement	Feb. 19, 2013		5 years from grant date		42,500		$	4.2	$	101,600
	Common stock warrants - Private Placement	Aug. 21, 2013		5 years from grant date		28,248		$	4
	Common stock warrants - Private Placement	Sept. 17, 2013		5 years from grant date		138,654		$	4
	Broker warrants - Private Placement	Sept. 17, 2013		5 years from grant date		13,865		$	2.38	$	10,330
	Common stock warrants - Private Placement	Oct. 29, 2013		5 years from grant date		122,128		$	4
	Broker warrants - Private Placement	Oct. 29, 2013		5 years from grant date		12,213		$	2.4	$	8,500
	Common stock warrants - Private Placement	Nov. 4, 2013		5 years from grant date		150,000		$	4
	Common stock warrants - Private Placement	Nov. 27, 2013		5 years from grant date		50,000		$	4
	Balance as at November 30, 2013					2,678,872
	During the year ended November 30, 2012, the Company issued 258,722 shares of Common Stock for cash at $7.67 per share and 26,075 Common Stock warrants at an exercise price of $7.67.  On October 1, 2013, the warrants were amended to extend the exercise period of one year from IPO issuance to two years from October 1, 2013 and decrease the exercise price from $7.67 to $5.00 per share.
	On November 23, 2011, the Company issued together with 130,378 shares of Common Stock, 65,189 Common Stock warrants at an exercise price of $7.67. The warrants were initially exercisable for a period of one year commencing from the date the Company starts trading publicly on the NASDAQ or the NYSE MKT. On October 1, 2013, the warrants were amended to extend the exercise period of one year from IPO issuance to two years from October 1, 2013 and decrease the exercise price from $7.67 to $5.00 per share.The warrant holders are generally protected from anti-dilution by adjustments for any stock dividends, stock split, combination or other recapitalizations. In addition, the Company was required to issue or cause to be transferred 52,151 shares of additional Common Stock as penalty shares on behalf of the Company, should the Company not be listed on the NASDAQ or the NYSE MKT, and did not meet certain operating requirements, on or before July 1, 2012. As the Company was not listed on the NASDAQ or the NYSE MKT, and did not meet certain operating requirements, by July 1, 2012, a Company's shareholder, Softdiffusion SA, transferred 52,151 shares of Common Stock with an estimated fair value of $7.67 per share to a new stockholder as settlement for the penalty share obligation. The estimated fair value of $399,998 for these shares have been recorded by the Company as part of the general and administrative expenses and charged to additional paid-in capital for the fiscal year ended November 30, 2012.
	As described in Note 1, on October 30, 2012, the Company completed an IPO pursuant to which it sold 560,000 Units, with an offering price of $5.00, and received net proceeds of $1.8 million, after deducting the underwriting fees and offering expenses. The total expenses amounting to $996,477 that were directly incurred in connection with the IPO, including underwriting fees, offering expenses and legal costs were charged against additional paid-in capital upon completion of the IPO. Each Unit consists of (i) one share of Common Stock, (ii) one Class A warrant, to purchase one share of Common Stock at an exercise price of $7.50, and (iii) one Class B warrant, to purchase one share of Common Stock at an exercise price of $10.00. The Class A and Class B warrants are exercisable for a period of five years commencing from the date of the IPO. Commencing six months after the date of the IPO, the Company may redeem some or all of the Class A warrants at a price of $0.05 per warrant after the closing bid price of its Common Stock has been at or above 200% of the unit offering price for five consecutive trading days, by giving the holders not less than 30 days’ notice. Commencing six months after the date of the IPO, the Company may redeem some or all of the Class B warrants at a price of $0.05 per warrant after it reports, for any four consecutive fiscal quarters, a total of $8 million of income before income taxes, by giving the holders not less than 30 days’ notice.
	On October 30, 2012, in connection with the IPO, the Company issued warrants to purchase 56,000 Units, identical to the Units offered under the IPO, with an exercise price of $6.00, to the representative of the underwriters of the offering. The fair value of these warrants at the date of the grant was $159,249. This amount was estimated using the Black-Scholes option pricing model with an expected life of 5 years, a risk free interest rate of 0.74%, a dividend yield of 0%, and an expected volatility of 75%.

13_STOCKBASED_COMPENSATION

13. STOCK-BASED COMPENSATION	12 Months Ended
	Nov. 30, 2013
Equity [Abstract]	'
13. STOCK-BASED COMPENSATION	'
	The Company’s Amended and Restated 2008 Directors, Officers and Employees Stock Option Plan, was originally approved by stockholders at the annual general meeting of the Company held on December 5, 2007, and subsequently amended by the stockholders on July 23, 2008. This plan was established to enable the Company to attract and retain the services of highly qualified and experienced directors, officers, employees and consultants and to give such persons an interest in the success of the Company and its subsidiaries. The total number of shares currently authorized under the plan is 391,134. The options and awards will be granted at the discretion of the Board of Directors. Options issued under the plan that are deemed to be incentive stock options will be priced at not less than 100% of the fair market value of the common shares at the date of the grant, subject to certain limitations for 10 percent stockholders. The fair value of each option granted is estimated at the time of grant using the Black-Scholes option pricing model using the following assumptions:
	Fiscal Year ended November 30,	2012		2013
	Exercise price ($)		7.67		7.67
	Risk-free interest rate		1.92% to 2.08%	1.59%
	Expected term (Years)		10		10
	Expected volatility		100%		100%
	Expected dividend yield		0%		0%
	Fair value of option ($)		6.86 to 6.90	1.83
	Expected forfeiture rate	Nil		Nil
	All the grants vest quarterly over a two year period and expire on the tenth anniversary of the grant date. The following table summarizes the stock option activities of the Company:
		Number of
		options
	Outstanding as of November 30, 2011		338,983
	Granted		44,327
	Outstanding as of November 30, 2012		383,310
	Granted		10,000
	Cancelled/forfeited		-27,379
	Outstanding as of November 30, 2013		365,931
	As of November 30, 2013 the Company has granted a total of 365,931 options to purchase common stock to employees, directors and advisory board members, all of which are currently outstanding and of which 353,922 are vested and exercisable. All of these outstanding stock options have an exercise price above the average market price.
	The Company recorded $246,949 and $87,907 in general and administrative expenses for share-based compensation expense for the years ended November 30, 2012 and 2013, respectively, with corresponding credits to additional paid-in capital. As of November 30, 2013, the total fair value of the options granted to employees at the respective grant dates was $1,476,973, of which the unrecognized portion of $13,088 related to the unvested shares associated with these stock option grants will be recognized over a period of two years. The Company will issue new shares upon exercise of the stock options.
	2012 Option Plan:
	Under the Company’s 2012 Directors, Officers and Employees Stock Option Plan the Company granted a total of 100,000 options to purchase Common Stock to its four independent directors and chief financial officer on April 2, 2013.  The total number of shares currently authorized under the plan is 400,000.  The options and awards will be granted at the direction of the Board of Directors. Options issued under the plan that are deemed to be incentive stock options will be priced at not less than 100 percent of the fair market value of the shares of Common Stock underlying the options at the date of the grant, subject to certain limitations for 10 percent stockholders. The fair value of each option granted was estimated at the time of grant using the Black-Scholes option pricing model.
	Fiscal Year ended November 30,	2012		2013
	Exercise price ($)		NA		3.94
	Risk-free interest rate		NA	0.78%
	Expected term (Years)		NA		5
	Expected volatility		NA		100%
	Expected dividend yield		NA		0%
	Fair value of option ($)		NA	2.93
	Expected forfeiture rate	NA		Nil
	All the grants vest yearly at the rate of 1/3 starting on the first year anniversary of the grant date and expire on the fifth anniversary of the grant date. The following table summarizes the stock option activities of the Company.
		Number of options
	Outstanding as of November 30, 2012		—
	Granted		100,000
	Exercised		—
	Cancelled/forfeited		—
	Outstanding as of November 30, 2013		100,000
	The share-based compensation for the fiscal year end November 30, 2013 was $106,152 (November 30, 2012 - $nil).
	As of November 30, 2013 the Company has granted options to purchase a total of 100,000 shares of Common Stock at an exercise price of $3.94 per share, to its four independent directors and chief financial officer, all of which are currently outstanding and of which none are vested and exercisable. All of these outstanding stock options have an exercise price equal to the fair market price on the date of grant. As of November 30, 2013, the total fair value of the options granted to the independent directors and chief financial officer at the respective grant dates was $292,174, of which the unrecognized portion of $186,022 related to the unvested shares associated with these stock option grants will be recognized over a period of three years.

14_FAIR_VALUE_MEASUREMENTS_CON

14. FAIR VALUE MEASUREMENTS, CONCENTRATIONS AND RISK	12 Months Ended
	Nov. 30, 2013
Fair Value Disclosures [Abstract]	'
14. FAIR VALUE MEASUREMENTS, CONCENTRATIONS AND RISK	'
	a)	The Company's cash and cash equivalents, which are carried at fair value, are classified as a level 1 financial instrument at November 30, 2012 and 2013.
	b)	The Company is exposed to the following concentrations of risk:
	Major Customers
	The Company's revenue was earned primarily from two major customers in 2013 comprising  67% and 30% of total revenue (2012 – revenue earned primarily from three major customers comprising 39%, 26% and 21% of total revenue).
	As at November 30, 2013, the accounts receivable  balance from the two major customers was $659,902 and $26,083 respectively (as at November 30, 2012 the accounts receivable balance from three major customers was $nil, $nil and $26,128 respectively).
	Major Vendor
	The Company has an exclusive agreement to manufacture biodiesel processor equipment with a third party equipment manufacturer expiring in August 2015. During the year ended November 30, 2013, the Company made purchases of $45,853 (November 30, 2012 - $2,611,266) from this equipment manufacturer. As of November 30, 2013, the Company has accounts payable of $21,856 (2012 - $51,414) owing to this equipment manufacturer.
	The Company’s major purchases of feedstock oil and biodiesel from third parties were primarily from three major vendors in fiscal 2013 comprising total purchases of $2,326,125, $1,754,302 and $1.720,589 (fiscal 2012 –two major vendor comprised total purchases of $2,198,053 and $1,376,403)
	As at November 30, 2013, the accounts payable balance from the three major vendors in 2013 were $nil, $1,053,479 and $575,043 (as at November 30, 2012 – the accounts payable balance from the two major vendors was $335,101 and $454,887).
	Economic and Political Risks
	The Company faces a number of risks and challenges as a result of having primary operations and marketing in Canada and sales in the United States.  Changing political climates in Canada and the United States could have a significant effect on the Company’s business.
	c)	The Company’s financial instruments are exposed to certain financial risks, including credit risk, currency risk and liquidity risk.
	Credit Risk
	Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations, and arises principally from the Company's cash and cash equivalents and trade accounts receivable. The Company places its cash and cash equivalents with institutions of high creditworthiness. The carrying value of the financial assets represents the maximum credit exposure.
	The Company minimizes credit risk by routinely reviewing the credit risk of the counterparty to the arrangement and has maintained an allowance for doubtful accounts of $30,000 related to credit risk as at November 30, 2013 and $30,000 as at November 30, 2012, which is considered adequate. Amounts of $26,128 and $685,985 were due from major customers as at November 30, 2012 and November 30, 2013, respectively.
	Currency Risk
	The Company is exposed to financial risk related to the fluctuation of foreign exchange rates.   The Company's functional currency is U.S. dollars.  A significant change in the currency exchange rates between the U.S. dollar relative to the Canadian dollar could have an effect on the Company's results of operations, financial position and cash flows.  The Company has not entered into any derivative financial instruments to manage exposures to currency fluctuations.
	Included in selling general and administrative expenses are foreign currency gains for the fiscal year ended November 30, 2013 of $127,450 (2012 - $37,875).
	Liquidity Risk
	Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due.  The Company has a planning and budgeting process in place to help determine the funds required to support the Company's normal operating requirements on an ongoing basis and its expansionary plans.  The Company ensures that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations and its holdings of cash.
	As at November 30, 2013, due in large part to the funds spent to develop and operate the Sombra facility, the Company had a working capital deficiency of $5,954,516. In order to meet its objectives, the Company required additional financing at November 30, 2013 to get the second machine at Sombra operational and to fund working capital.
	The Company anticipates that its Sombra facility will generate positive cash flow from operations and will operate profitably once full-scale commercial operations are achieved in the second quarter of fiscal year 2014. It is management’s opinion that the anticipated positive cash flows from operations, cash from additional and refinanced loans along with the proceeds from the subsequent Private Placement referred to in Note 18 will be sufficient to meet the Company’s cash requirements for at least the next 12 months.

15_COMMITMENTS

15. COMMITMENTS	12 Months Ended
	Nov. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
15. COMMITMENTS	'
	Building Leases:
	Methes Canada is a party to a lease agreement for the Mississauga facility and to a sublease agreement for a unit adjacent to its Mississauga facility. On September 28, 2012, the Company re-negotiated and renewed a combined five year lease term for both of these facilities starting from January 1, 2013 to December 31, 2017. The renewed lease term provides for a two month rent free period in 2013.
	As at November 30, 2013, Methes Canada must pay, in addition to other amounts such as its pro rata share of taxes, the following amounts over the term of the lease:
			Annual
			Minimum Rent
	2014		$	139,110
	2015		$	139,110
	2016		$	139,110
	2017		$	139,110
	2018		$	11,593
	Railroad Car Leases:
	As at November 30, 2013, the Company is a party to the following lease agreements for railcars at its Sombra facility:
		Start Date		End Date	Term
	Four railcars at $3,100 per month	1-Aug-13		31-Jul-18	60 months
	Four railcars at $3,100 per month	1-Apr-13		31-Mar-18	60 months
	Four railcars at $ 3,600 per month	1-Jul-13		30-Jun-18	60 months
	Four railcars at $3,140  per month	1-Dec-11		30-Nov-16	60 months
	One railcar at $575 per month	1-Jan-12		31-Dec-16	60 months
	One railcar at $575 per month	1-May-12		30-Jun-15	36 months
	Ten railcars at $8,460 per month	1-May-13		30-Apr-18	60 months
	Ten railcars at $8,510 per month	1-May-13		30-Apr-18	60 months
			Annual
			Minimum Rent
	2014		$	372,720
	2015		$	369,845
	2016		$	365,820
	2017		$	321,815
	2018		$	147,250

16_CONTRIBUTION_AGREEMENTS_WIT

16. CONTRIBUTION AGREEMENTS WITH MINISTER OF NATURAL RESOURCES OF CANADA	12 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
16. CONTRIBUTION AGREEMENTS WITH MINISTER OF NATURAL RESOURCES OF CANADA	'
	Mississauga Facility:
	In 2009, the Company entered into a Non-Refundable Contribution Agreement with the Minister of Natural Resources of Canada for the Mississauga facility under the ecoENERGY for Biofuels program. Under this agreement, as amended, the Company may receive up to $5,094,056 (CDN$5,410,000) in the years from 2009 to 2016 from the Canadian government in biodiesel production incentives when biodiesel is produced and sold. The contribution from the Canadian Government is non-refundable by the Company.
	For the year ended November 30, 2013, the Company claimed incentives of $10,171 (2012 - $299,540).  Since entering into the program to November 30, 2013, the Company has claimed total incentives of $1,458,286 and has received total amount of $1,458,286.
	Included in accounts receivable as at November 30, 2012 and 2013 is an amount receivable of $46,816 and $nil respectively, due from the Minister of Natural Resources of Canada.
	Sombra Facility:
	In 2010, the Company applied for an incentive under the ecoENERGY for Biofuels program for its Sombra facility and was approved by the Canadian government. The final Contribution Agreement with the Minister of Natural Resources of Canada for the Sombra facility under the ecoENERGY for Biofuels program was signed by the Company and the Canadian Government on December 6, 2011.  Under this agreement, as amended, the Company may receive up to $13,921,744 (CDN$14,785,200) in the years from 2012 to 2017 from the Canadian government in biodiesel production incentives when biodiesel is produced and sold. The contribution from the Canadian Government is non-refundable by the Company.
	For the year ended November 30, 2013, the Company claimed incentives of $536,875 (2012 - $nil).  Since entering into the program to November 30, 2013, the Company has claimed total incentives of $536,875 and has received total amount of $259,302.
	Included in accounts receivable as at November 30, 2012 and 2013 is an amount receivable of $nil and $277,573 respectively, due from the Minister of Natural Resources of Canada.

17_SEGMENT_INFORMATION

17. SEGMENT INFORMATION	12 Months Ended
	Nov. 30, 2013
Segment Reporting [Abstract]	'
17. SEGMENT INFORMATION	'
	The Company's assets and operating facilities, other than cash and cash equivalents balances of $336,065 at November 30, 2012 and $16,066 at November 30, 2013, are all located in Canada. The Company services the majority of its customers in the United States.  The Company derives its revenue geographically as follows:
		Year Ended		Year Ended
		November 30,		November 30,
		2012		2013
	Revenue
	United States	$	5,678,693	$	7,749,825
	Canada		871,055		1,120,112
		$	6,549,748	$	8,869,937

18_SUBSEQUENT_EVENTS

18. SUBSEQUENT EVENTS	12 Months Ended
	Nov. 30, 2013
Subsequent Events [Abstract]	'
18. SUBSEQUENT EVENTS	'
	The Company has performed an evaluation of subsequent events and has determined there have been the following material subsequent events requiring disclosure:
	On December 9, 2013, the Company signed a Letter of Intent (“LOI”) to acquire the assets of OTC Energy Technologies Inc. (“OTC”), including all of OTC’s technologies and know how relating to the conversion of several types of biomass into a chemical quality syngas which can be converted into renewable alcohols and fuels. The LOI is subject to execution and delivery of a mutually satisfactory purchase agreement and is not a binding commitment of either party.
	On December 16, 2013, Methes Canada entered into a one year term Mortgage Loan Agreement for $2,000,000 (CDN) at 9% per annum for the purposes of discharging the existing Term loan (July 2013) of $1,600,000 (CDN).  The difference will be used to upgrade the Mississauga facility for the production of biodiesel. Interest only is to be paid monthly and the term of one year has an option to renew for another year.
	On December 20, 2013, the Company completed the Common Stock Unit Private Placement and issued an additional 1,081,161 Common Stock Units to accredited investors at a price of $2.00 per unit which raised additional net proceeds of approximately $1,877,000, after deducting the sales commission and fees.
	On January 10, 2014, the Company sold 50,000 Common Stock Units to an accredited investor for a purchase price of $125,000 (or $2.50 per Common Stock Unit) of which, $100,000 was paid in cash and $25,000 will be paid in services to be rendered to the Company.
	On January 17, 2014, the Company converted $128,000 USD (CDN $139,845) of the outstanding principal due on the January 2013 Note into 34,688 shares of Common Stock based on the closing market price of $3.69 per share of Common Stock on January 17, 2014.
	On January 28, 2014, the Company borrowed $172,000 from a lender and issued to the lender a demand promissory note in the principal amount of $172,000 bearing interest of 8% per annum (the “New Note”). Repayment of the principal and accrued interest on the New Note will be due upon demand.
	On January 30, 2014, the Company used the proceeds from the New Note to partially repay the January 2013 Note.
	On February 13, 2014, Methes Canada entered into an agreement with a Canadian Company to produce biodiesel at the Mississauga facility. Pursuant to that agreement: (i) Methes Canada has agreed to provide use and occupancy of the Mississauga facility to the Canadian Company for a term of 18 months commencing May 1, 2014,  with an option to renew, for a monthly minimum payment of $6,960 (CDN); and (ii) the Canadian Company will provide the working capital for the production of biodiesel including the purchase of feedstock and other commodities for the purpose of biodiesel production.

2_SUMMARY_OF_SIGNIFICANT_ACCOU1

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Nov. 30, 2013
Accounting Policies [Abstract]	'
Basis of Presentation	'
	The consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and are expressed in United States dollars. The Company’s fiscal year-end is November 30.
	The Company is an emerging growth company (EGC) pursuant to Jumpstart Our Business Startups Act of 2012 (the JOBS Act). Under Section 102(b) of the JOBS Act, the Company has elected to apply any new or revised financial accounting standard on the same date a company that is not an issuer is required to apply the new or revised accounting standard, if the standard applies to a non-issuer. If the new or revised accounting standard does not apply to a non-issuer, then the Company will apply it according to the transition provisions for a non-EGC. The Company’s election to use the extended transition period for complying with new or revised accounting standards under Section 102(b) of the JOBS Act had no impact on the consolidated financial statements as of November 30, 2013 and 2012.
Basis of Consolidation	'
	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Methes Canada and Methes USA.  All significant inter-company transactions and balances have been eliminated. Methes Canada was incorporated on December 23, 2004, and became a wholly-owned subsidiary of the Company on September 5, 2007. Methes USA was incorporated as a wholly-owned subsidiary of the Company on June 27, 2007.
Use of Estimates	'
	The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Areas involving significant estimates and assumptions include: inventory valuation reserves; allowance for doubtful accounts; deferred income tax liabilities and assets, and related valuation allowances; expected future cash flows used in evaluating intangible assets and property, plant and equipment for impairment; estimated useful life of property, plant and equipment and intangible assets; and valuation of stock options and broker warrants. The estimates and assumptions made require judgment on the part of management and are based on the Company’s historical experience and various other factors that are believed to be reasonable in the circumstances. Management continually evaluates the information that forms the basis of its estimates and assumptions as the business of the Company and the business environment generally changes. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s consolidated financial statements could be materially impacted.
Cash and Cash Equivalents	'
	The Company considers all highly liquid investments with a maturity of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents consist primarily of bank deposits held in the United States and Canada.
Inventories	'
	The Company’s inventories consist primarily of bulk biodiesel, methanol, catalyst, crude glycerin and biodiesel processing equipment and are valued at the lower of cost and market value, with cost determined on a weighted average basis. Cost for finished goods inventories includes materials, direct labor, and an allocation of overheads. Market for raw materials is replacement cost, and for finished goods is net realizable value.
	The Company evaluates the carrying value of inventories on a regular basis, taking into account such factors as historical and anticipated future sales compared with quantities on hand and the price the Company expects to obtain for products in the market compared with historical cost.
Allowance for Doubtful Accounts	'
	The Company establishes an allowance for doubtful accounts based on management’s assessment of the collectability of trade receivables.  A considerable amount of judgment is required in assessing the amount of the allowance.  The Company makes judgments about the creditworthiness of each customer based on ongoing credit evaluations, and monitors current economic trends that might impact the level of credit losses in the future.  If the financial condition of the customers were to deteriorate, resulting in their inability to make payments, a specific allowance will be required. Account balances are charged off against the allowance when the Company believes it is probable the receivable will not be recovered.
Revenue Recognition	'
	Revenue is recognized in accordance with ASC 605, "Revenue Recognition in Financial Statements."  Under ASC 605, product or service revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or service has been performed, the sales price is fixed and determinable and collectability is reasonably assured. The Company has not experienced any material expense in satisfying warranties. Details of specific recognition by product or service categories are as follows:
	Revenue from the sale of biodiesel and its co-product, biodiesel processing equipment and feedstock is recognized when title and possession of the product is transferred to the customer. Possession is transferred to the customer at the time of shipment from the Company’s facility or at the time of delivery to a specified destination, depending on the terms of the sale.
	The ecoENERGY incentive is recognized as revenue when the right to receive is established upon production and sale of biodiesel.
	Revenue from services is recognized as services are performed.
	Royalty revenue is recognized on an accrual basis in accordance with the Sales & Licensing Agreement of the biodiesel processing equipment sale. Royalty is charged on gallons of biodiesel produced by the Company's customers using the Company’s biodiesel processing equipment.
Shipping and Handling Costs	'
	The Company accounts for shipping and handling fees in accordance with FASB ASC 705 “Cost of Sales and Services”. Shipping and handling costs for the years ended November 30, 2012 and 2013 were $344,146 and $309,675, respectively. Costs related to raw materials purchased, are included in inventory or cost of goods sold, as appropriate. While amounts charged to customers for shipping product are included in revenues, the related outbound freight costs are included in expenses as incurred.
Deferred Financing Fees	'
	Costs directly incurred in connection with the IPO were recorded as deferred financing fees until the completion of the IPO. These deferred financing fees were charged against additional paid-in capital upon completion of the IPO. Financing fees relating to other financing arrangements are deferred and amortized over the term of the respective loan. Deferred financing fees as at November 30, 2012 and 2013 were $26,334 and $49,139, respectively.
Financial Instruments	'
	The Company’s financial instruments recognized in the consolidated balance sheets and included in working capital consist of cash and cash equivalents, accounts receivable, credit facility, accounts payable and accrued liabilities, amounts due to related parties and other, and short-term loan. The fair values of these instruments approximate their carrying values due to their short-term maturities.
Fair Value Measurements	'
	Financial instruments that are measured subsequent to initial recognition at fair value are grouped into hierarchy based on the degree to which the fair value inputs are observable.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., an exit price). Fair value measurements are estimated based on inputs categorized as follows:
	Level 1 inputs include quoted prices (unadjusted) for identical assets or liabilities in active markets that are observable.
	Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	Level 3 includes unobservable inputs that reflect the Company's own assumptions about what factors market participants would use in pricing the asset or liability.
	When measuring fair value, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs.
Foreign Currency Translation	'
	The functional currency of the Company and its subsidiaries is the United States dollar. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction.  Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities are translated using the historical rate on the date of the transaction. Revenue and expenses are translated at average rates in effect during the reporting periods. All exchange gains or losses arising from translation of these foreign currency transactions are included in net income (loss) for the year. The Company has not, to the date of these consolidated financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.
Income Taxes and Uncertain Tax Positions	'
	The Company accounts for income taxes under ASC 740 Accounting for Income Taxes. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. ASC 740-10-05, Accounting for Uncertainty in Income Taxes, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return.
	For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
	The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Potential tax benefits from net operating losses and foreign tax credit carry forwards are not recognized by the Company until their realization is more likely than not. We assess the validity of our conclusions regarding uncertain tax positions on a quarterly basis to determine if facts or circumstances have arisen that might cause us to change our judgment regarding the likelihood of a tax position’s sustainability under audit.  The Company has determined that there were no material uncertain tax positions as at November 30, 2012 and 2013.
Stock-based Compensation	'
	The Company maintains a stock-based compensation plans under which incentive stock options to buy Common Stock may be granted to directors, officers and employees. Pursuant to ASC 718, the Company recognizes expense for its stock-based compensation based on the fair value of the awards that are granted. The fair values of stock options are estimated at the date of grant using the Black-Scholes option pricing model, that require the input of highly subjective assumptions. Measured compensation cost is recognized ratably over the vesting period of the related stock-based compensation award. The amount recognized as expense is adjusted to reflect the number of stock options expected to vest. When exercised, stock options are settled through the issuance of Common Stock and are therefore treated as equity awards. The expected volatility of our Common Stock is estimated using an average of volatilities of publicly traded companies in similar renewable energy businesses.
Property, Plant and Equipment	'
	Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is provided using the straight-line basis at the following annual rates reflecting the estimated useful lives of the assets:
	Sombra facility:
	Building	40 years
	Equipment	5 years
	Equipment - Denami 3000	25 years
	Computer equipment	2 years
	Vehicle	10 years
	Mississauga facility:
	Computer equipment	2 years
	Leasehold improvements	Over the lease term
	Equipment and fixtures	5 years
	Equipment - Denami 600	25 years
Intangible Assets	'
	The Company’s finite-lived intangible assets consist of acquired intellectual property from a third party for the design and engineering of Denami 600 and Denami 3000 biodiesel processor equipment.  The intangible assets related to the Denami 600 and Denami 3000 are recorded at cost, less accumulated amortization and the amortization is provided over their 25 year estimated useful life on a straight-line basis.
Impairment of Long-Lived Assets	'
	The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amounts of the assets may not be recoverable through undiscounted future cash flows. If impairment exists based on expected future undiscounted cash flows, a loss is recognized in income. The amount of the impairment loss is the excess of the carrying amount of the impaired asset over the fair value of the asset, typically based on discounted future cash flows. The Company has assessed its long-lived assets and has determined that there was no impairment in their carrying amounts at November 30, 2012 and 2013.
Per Share Data	'
	Basic earnings per share (“EPS”) is determined by dividing net earnings available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the year. In computing diluted EPS, the average number of shares of Common Stock outstanding is increased by Common Stock options and warrants outstanding if the exercise prices were lower than the average market price of Common Stocks using the treasury stock method. Diluted earnings per share exclude all potentially dilutive shares if their effect is anti-dilutive. Potentially dilutive shares include 1,267,264 warrants and 383,310 Common Stock options issued and outstanding as at November 30, 2012 and 2,678,872 warrants, 260,782 Preferred Stock and 465,931 Common Stock options issued and outstanding as at November 30, 2013. All outstanding warrants, preferred stocks and options have an anti-dilutive effect on the loss per share and are therefore excluded from the determination of the 2012 and 2013 diluted loss per share calculation.
Recent Accounting Pronouncements	'
	In September 2011, the FASB issued ASU 2011- 08, Intangibles - Goodwill and Other, which amends ASC Topic 350 and the current guidance on testing goodwill for impairment. Under the revised guidance, entities testing goodwill for impairment have the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit exceeds its carrying amount. If an entity determines it is more likely than not that the fair value of a reporting unit exceeds its carrying amount, then performing the two-step impairment test is unnecessary. The amendments are effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. The Company adopted this statement effective December 1, 2012. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements.In December 2011, the FASB issued ASU No. 2011-11, Disclosures about Offsetting Assets and Liabilities (Topic 210). The new disclosure requirements mandate that entities disclose both gross and net information about instruments and transactions eligible for offset in the statement of financial position as well as instruments and transactions subject to an agreement similar to a master netting arrangement. In addition, the standard requires disclosure of collateral received and posted in connection with master netting agreements or similar arrangements. The amendments are effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The disclosures required by the amendments are required to be applied retrospectively for all comparative periods presented. The Company does not believe the adoption of this standard will have a material impact on its consolidated financial statements.All other recent pronouncements issued by the FASB or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the consolidated financial statements of the Company.

2_SUMMARY_OF_SIGNIFICANT_ACCOU2

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Nov. 30, 2013
Summary Of Significant Accounting Policies Tables	'
Estimated useful lives schedule	'
	Sombra facility:
	Building	40 years
	Equipment	5 years
	Equipment - Denami 3000	25 years
	Computer equipment	2 years
	Vehicle	10 years
	Mississauga facility:
	Computer equipment	2 years
	Leasehold improvements	Over the lease term
	Equipment and fixtures	5 years
	Equipment - Denami 600	25 years

3_ACCOUNTS_RECEIVABLE_Tables

3. ACCOUNTS RECEIVABLE (Tables)	12 Months Ended
	Nov. 30, 2013
Receivables [Abstract]	'
Accounts receivable	'
		As at		As at
		November 30,		November 30,
		2012		2013
	Trade receivables	$	333,418	$	1,184,916
	Allowance for doubtful accounts		-30,000		-30,000
		$	303,418	$	1,154,916

4_INVENTORIES_Tables

4. INVENTORIES (Tables)	12 Months Ended
	Nov. 30, 2013
Inventory Disclosure [Abstract]	'
Schedule of Inventories	'
		As at		As at
		November 30,		November 30,
		2012		2013
	Raw materials	$	330,627	$	345,049
	Finished goods		739,205		444,648
	Equipment (i)		126,966		11,366
		$	1,196,798	$	801,063

5_PROPERTY_PLANT_AND_EQUIPMENT1

5. PROPERTY, PLANT AND EQUIPMENT (Tables)	12 Months Ended
	Nov. 30, 2013
Property, Plant and Equipment [Abstract]	'
Schedule of Property, Plant and Equipment	'
		As at November 30, 2012
				Accumulated		Net Book
		Cost		Depreciation		Value
	Sombra site:
	Land	$	409,134	$	-	$	409,134
	Building		2,820,294		168,663		2,651,631
	Equipment		727,020		257,475		469,545
	Equipment - Denami 3000		3,964,293		25,059		3,939,234
	Mississauga site:
	Computer equipment		30,014		20,589		9,425
	Leasehold improvements		102,202		45,218		56,984
	Equipment and fixtures		255,463		146,782		108,681
	Equipment - Denami 600		720,042		132,850		587,192
		$	9,028,462	$	796,636	$	8,231,826
		As at November 30, 2013
				Accumulated		Net Book
		Cost		Depreciation		Value
	Sombra site:
	Land	$	409,134	$	-	$	409,134
	Building		2,944,356		241,910		2,702,446
	Equipment		775,865		385,400		390,465
	Equipment - Denami 3000		4,164,968		189,527		3,975,441
	Computer equipment		11,835		5,917		5,918
	Vehicle		11,622		291		11,331
	Mississauga site:
	Computer equipment		23,464		22,148		1,316
	Leasehold improvements		102,201		55,610		46,591
	Equipment and fixtures		255,463		177,801		77,662
	Equipment - Denami 600		720,042		161,652		558,390
		$	9,418,950	$	1,240,256	$	8,178,694

6_INTANGIBLE_ASSETS_Tables

6. INTANGIBLE ASSETS (Tables)	12 Months Ended
	Nov. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Major components of finite-lived intangible assets	'
		As at November 30, 2012
				Accumulated		Net Book
		Cost		Amortization		Value
	Denami 600	$	414,174	$	91,477	$	322,697
	Denami 3000		90,735		405		90,330
		$	504,909	$	91,882	$	413,027
		As at November 30, 2013
				Accumulated		Net Book
		Cost		Amortization		Value
	Denami 600	$	414,174		108,045	$	306,129
	Denami 3000		90,927		4,041		86,886
		$	505,101	$	112,086	$	393,015
Estimated future aggregate amortization expense	'
		2014		2015		2016		2017		2018		Thereafter
	Amortization expense	$	20,202	$	20,202	$	20,202	$	20,202	$	20,202	$	292,005

7_ACCOUNTS_PAYABLE_AND_ACCRUED1

7. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)	12 Months Ended
	Nov. 30, 2013
Payables and Accruals [Abstract]	'
Accounts payable and accrued liabilities	'
		As at		As at
		November 30,		November 30,
		2012		2013
	Accounts payable	$	1,128,115	$	2,766,661
	Accrued liabilities		634,551		211,296
		$	1,762,666	$	2,977,957

8_SHORTTERM_LOANS_Tables

8. SHORT-TERM LOANS (Tables)	12 Months Ended
	Nov. 30, 2013
Short-Term Loans Tables	'
Short term loans	'
		As at		Advances and Reallocations		Interest Accrued		Repayments		Foreign Exchange Adjustments		As at
		November 30,										November 30,
		2012										2013
	Term loan (June 2012)	$	1,509,600	$	-	$	-	$	-1,444,350	$	-65,250	$	-
	Term loan (July 2013)		-		1,540,640		-		-		-34,080		1,506,560
	Promissory note (i)		-		49,333		3,200		-		-		52,533
	Promissory note (ii)		-		397,400		25,915		-		-20,757		402,558
		$	1,509,600	$	1,987,373	$	29,115	$	-1,444,350	$	-120,087	$	1,961,651

10_PAYABLE_TO_RELATED_PARTIES_1

10. PAYABLE TO RELATED PARTIES AND OTHERS (Tables)	12 Months Ended
	Nov. 30, 2013
Related Party Transactions [Abstract]	'
Schedule of Payable to Related Parties and Others	'
		As at		As at
		November 30,		November 30,
		2012		2013
	Michel G. Laporte (stockholder and Director)	$	172,389	$	719,230
	World Asset Management Inc. (stockholder)		1,396,277		1,495,477
	Soft Diffusion SA (see note 8 (i))		49,333		-
	Other loan		-		36,695
		$	1,617,999	$	2,251,402

11_INCOME_TAXES_Tables

11. INCOME TAXES (Tables)	12 Months Ended
	Nov. 30, 2013
Income Tax Disclosure [Abstract]	'
Tax reconciliation	'
		Year Ended			Year Ended
		November 30,			November 30,
		2012			2013
	Loss before income taxes	$	3,966,765		$	5,651,665
	Expected income tax recovery		(1,388,368	)		-1,978,080
	Non-deductible expenses		220,364			74,570
	Difference in foreign tax rates, changes in tax rate, foreign exchange impact on translation of tax base and other adjustments		87,315			558,030
	Change in valuation allowance		1,080,689			1,345,480
		$	-		$	-
Deferred income tax assets and liabilities	'
		As at			As at
		November 30,			November 30,
		2012			2013
	Deferred income tax assets
	Non-capital losses carried forward	$	2,453,326		$	4,024,820
	Less: allocated against deferred tax liabilities		(405,383	)		-631,390
	Less: valuation allowance		(2,047,943	)		-3,393,430
		$	-		$	-
	Deferred tax liabilities
	Property, plant and equipment and intangible assets	$	405,383		$	631,390
	Less: offset by deferred tax assets		(405,383	)		-631,390
		$	-		$	-

12_STOCKHOLDERS_EQUITY_Tables

12. STOCKHOLDERS' EQUITY (Tables)	12 Months Ended
	Nov. 30, 2013
Stockholders Equity Tables	'
Schedule of common stock	'
			No. of Shares			Price per Share
	Common Stock
	Balance as at November 30, 2011			5,734,447
	Issuance for cash			258,722		$	7.67
	October 2012 – IPO issuance			560,000		$	5
	Balance as at November 30, 2012			6,553,169
	February 2013 Private Placement			425,000		$	4
	August 2013 Private Placement			28,248		$	1.77
	November 2013 Private Placement			200,000		$	2
	November 2013 Issuance			25,000		$	2.08
				7,231,417
Schedule of preferred stock	'
			No. of Shares			Price per Share
	Preferred Stock
	Balance as at November 30, 2012			-
	Series A-1 Private Placement			138,654		$	2.38
	Series A-2 Private Placement			122,128		$	2.395
				260,782
Schedule of stock warrants	'
		Grant Date		Exercise Period	No of Warrants			Exercise Price per share		Fair Value of Broker Warrants
	Balance as at November 30, 2011	Nov. 23, 2011		2 years from October 1, 2013		65,189		$	5
	Warrants issued	Jan. 27, 2012		2 years from October 1, 2013		26,075		$	5
	Class A warrants - IPO related	Oct. 12, 2012		5 years from October 30, 2013		560,000		$	7.5
	Class B warrants - IPO related	Oct. 12, 2012		5 years from October 30, 2013		560,000		$	10
	Broker Warrants related to IPO	Oct. 12, 2012		5 years from October 30, 2013		56,000		$	6	$	159,250
	Class A warrants	Oct. 25, 2012		5 years from October 30, 2013		2,000		$	7.5
	Class B warrants	Oct. 25, 2012		5 years from October 30, 2013		2,000		$	10
	Balance as at November 30, 2012					1,271,264
	Class A warrants - Private Placement	Feb. 19, 2013		5 years from grant date		425,000		$	7.5
	Class B warrants - Private Placement	Feb. 19, 2013		5 years from grant date		425,000		$	10
	Broker warrants - Private Placement	Feb. 19, 2013		5 years from grant date		42,500		$	4.2	$	101,600
	Common stock warrants - Private Placement	Aug. 21, 2013		5 years from grant date		28,248		$	4
	Common stock warrants - Private Placement	Sept. 17, 2013		5 years from grant date		138,654		$	4
	Broker warrants - Private Placement	Sept. 17, 2013		5 years from grant date		13,865		$	2.38	$	10,330
	Common stock warrants - Private Placement	Oct. 29, 2013		5 years from grant date		122,128		$	4
	Broker warrants - Private Placement	Oct. 29, 2013		5 years from grant date		12,213		$	2.4	$	8,500
	Common stock warrants - Private Placement	Nov. 4, 2013		5 years from grant date		150,000		$	4
	Common stock warrants - Private Placement	Nov. 27, 2013		5 years from grant date		50,000		$	4
	Balance as at November 30, 2013					2,678,872

13_STOCKBASED_COMPENSATION_Tab

13. STOCK-BASED COMPENSATION (Tables)	12 Months Ended
	Nov. 30, 2013
Stock-Based Compensation Tables	'
Fair value assumtions used	'
	Fiscal Year ended November 30,	2012		2013
	Exercise price ($)		7.67		7.67
	Risk-free interest rate		1.92% to 2.08%	1.59%
	Expected term (Years)		10		10
	Expected volatility		100%		100%
	Expected dividend yield		0%		0%
	Fair value of option ($)		6.86 to 6.90	1.83
	Expected forfeiture rate	Nil		Nil
Stock option activities	'
		Number of
		options
	Outstanding as of November 30, 2011		338,983
	Granted		44,327
	Outstanding as of November 30, 2012		383,310
	Granted		10,000
	Cancelled/forfeited		-27,379
	Outstanding as of November 30, 2013		365,931
Fair value assumtions used - 2012 Option Plan	'
	Fiscal Year ended November 30,	2012		2013
	Exercise price ($)		NA		3.94
	Risk-free interest rate		NA	0.78%
	Expected term (Years)		NA		5
	Expected volatility		NA		100%
	Expected dividend yield		NA		0%
	Fair value of option ($)		NA	2.93
	Expected forfeiture rate	NA		Nil
Stock option activities - 2012 Option Plan	'
		Number of options
	Outstanding as of November 30, 2012		—
	Granted		100,000
	Exercised		—
	Cancelled/forfeited		—
	Outstanding as of November 30, 2013		100,000

15_COMMITMENTS_Tables

15. COMMITMENTS (Tables)	12 Months Ended
	Nov. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Annual Minimum Rent	'
			Annual
			Minimum Rent
	2014		$	139,110
	2015		$	139,110
	2016		$	139,110
	2017		$	139,110
	2018		$	11,593
Schedule of lease agreements	'
		Start Date		End Date	Term
	Four railcars at $3,100 per month	1-Aug-13		31-Jul-18	60 months
	Four railcars at $3,100 per month	1-Apr-13		31-Mar-18	60 months
	Four railcars at $ 3,600 per month	1-Jul-13		30-Jun-18	60 months
	Four railcars at $3,140  per month	1-Dec-11		30-Nov-16	60 months
	One railcar at $575 per month	1-Jan-12		31-Dec-16	60 months
	One railcar at $575 per month	1-May-12		30-Jun-15	36 months
	Ten railcars at $8,460 per month	1-May-13		30-Apr-18	60 months
	Ten railcars at $8,510 per month	1-May-13		30-Apr-18	60 months
Schedule of annual minimum rental payments	'
			Annual
			Minimum Rent
	2014		$	372,720
	2015		$	369,845
	2016		$	365,820
	2017		$	321,815
	2018		$	147,250

17_SEGMENT_INFORMATION_Tables

17. SEGMENT INFORMATION (Tables)	12 Months Ended
	Nov. 30, 2013
Segment Reporting [Abstract]	'
Schedule of Revenue Geographically	'
		Year Ended		Year Ended
		November 30,		November 30,
		2012		2013
	Revenue
	United States	$	5,678,693	$	7,749,825
	Canada		871,055		1,120,112
		$	6,549,748	$	8,869,937

1_BASIS_OF_PRESENTATION_AND_NA

1. BASIS OF PRESENTATION AND NATURE OF THE BUSINESS (Details Narrative) (USD $)	12 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Basis Of Presentation And Nature Of Business Details Narrative	'	'
Working capital deficiency	$5,954,516	'
Loss incurred	5,651,665	3,966,765
Net cash used in operating activities	($4,134,950)	($2,973,791)

2_SUMMARY_OF_SIGNIFICANT_ACCOU3

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	Nov. 30, 2013
Sombra facility:	'
Building	'40 years
Equipment	'5 years
Equipment - Denami 3000	'25 years
Computer equipment	'2 years
Vehicle	'10 years
Mississauga facility:	'B
Computer equipment	'2 years
Leasehold improvements	'OVER THE LEASE TERM
Equipment and fixtures	'5 years
Equipment - Denami 600	'25 years

2_SUMMARY_OF_SIGNIFICANT_ACCOU4

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (USD $)	12 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Summary Of Significant Accounting Policies Details Narrative	'	'
Shipping and handling costs	$309,675	$344,146

3_ACCOUNTS_RECEIVABLE_Details

3. ACCOUNTS RECEIVABLE (Details) (USD $)	Nov. 30, 2013	Nov. 30, 2012
Accounts Receivable Details	'	'
Trade receivables	$1,184,916	$333,418
Allowance for doubtful accounts	-30,000	-30,000
Accounts receivable, net	$1,154,916	$303,418

4_INVENTORIES_Details

4. INVENTORIES (Details) (USD $)	Nov. 30, 2013	Nov. 30, 2012
Inventories Details	'	'
Raw materials	$345,049	$330,627
Finished goods	444,648	739,205
Equipment	11,366	126,966
Inventory, Total	$801,063	$1,196,798

5_PROPERTY_PLANT_AND_EQUIPMENT2

5. PROPERTY, PLANT AND EQUIPMENT (Details) (USD $)	Nov. 30, 2013	Nov. 30, 2012
Property, plant and equipment, net	$8,178,694	$8,231,826
Sombra - Cost	'	'
Land	409,134	409,134
Building	2,944,356	2,820,294
Equipment	775,865	727,020
Equipment - Denami 3000 (underB construction)	4,164,968	3,964,293
Computer equipment	11,835	'
Vehicle	11,622	'
Sombra - Accumulated Depreciation	'	'
Land	0	0
Building	241,910	168,663
Equipment	385,400	257,475
Equipment - Denami 3000 (underB construction)	189,527	25,059
Computer equipment	5,917	'
Vehicle	291	'
Sombra - NetBookValue	'	'
Land	409,134	409,134
Building	2,702,446	2,651,631
Equipment	390,465	469,545
Equipment - Denami 3000 (underB construction)	3,975,441	3,939,234
Computer equipment	5,918	'
Vehicle	11,331	'
Mississauga - Cost	'	'
Computer equipment	23,464	30,014
Leasehold improvements	102,201	102,202
Equipment and fixtures	255,463	255,463
Equipment - Denami 600	720,042	720,042
Mississauga - Accumulated Depreciation	'	'
Computer equipment	22,148	20,589
Leasehold improvements	55,610	45,218
Equipment and fixtures	177,801	146,782
Equipment - Denami 600	161,652	132,850
Mississauga - NetBookValue	'	'
Computer equipment	1,316	9,425
Leasehold improvements	46,591	56,984
Equipment and fixtures	77,662	108,681
Equipment - Denami 600	$558,390	$587,192

5_PROPERTY_PLANT_AND_EQUIPMENT3

5. PROPERTY, PLANT AND EQUIPMENT (Details Narrative) (USD $)	12 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Property Plant And Equipment Details Narrative	'	'
Depreciation Expense	$443,619	$241,083

6_INTANGIBLE_ASSETS_Details

6. INTANGIBLE ASSETS (Details) (USD $)	Nov. 30, 2013	Nov. 30, 2012
Intangible assets, net	$393,015	$413,027
Cost	'	'
Denami 600	414,174	414,174
Denami 3000	90,927	90,735
Intangible assets, net	505,101	504,909
Accumulated Amortization	'	'
Denami 600	108,045	91,477
Denami 3000	4,041	405
Intangible assets, net	112,086	91,882
Net Book Value	'	'
Denami 600	306,129	322,697
Denami 3000	86,886	90,330
Intangible assets, net	$393,015	$413,027

6_INTANGIBLE_ASSETS_Details_1

6. INTANGIBLE ASSETS (Details 1) (USD $)	Nov. 30, 2012
Intangible Assets Details 1	'
2014	$20,202
2015	20,202
2016	20,202
2017	20,202
2018	20,202
Thereafter	$292,005

8_SHORTTERM_LOANS_Details

8. SHORT-TERM LOANS (Details) (USD $)	12 Months Ended
	Nov. 30, 2013
Beginning Balance	$1,509,600
Advances and Reallocations	1,987,373
Interest Accrued	29,115
Repayments	-144,350
Foreign Exchange Adjustments	-120,087
Ending Balance	1,960,651
TermLoan 1	'
Beginning Balance	1,509,600
Advances and Reallocations	'
Interest Accrued	'
Repayments	-1,444,350
Foreign Exchange Adjustments	-62,250
Ending Balance	'
TermLoan 2	'
Beginning Balance	'
Advances and Reallocations	1,540,640
Interest Accrued	'
Repayments	'
Foreign Exchange Adjustments	-34,080
Ending Balance	1,506,560
Promissory Note 1	'
Beginning Balance	'
Advances and Reallocations	49,333
Interest Accrued	3,200
Repayments	'
Foreign Exchange Adjustments	'
Ending Balance	52,533
Promissory Note 2	'
Beginning Balance	'
Advances and Reallocations	397,400
Interest Accrued	25,915
Repayments	'
Foreign Exchange Adjustments	-20,757
Ending Balance	$402,558

10_PAYABLE_TO_RELATED_PARTIES_2

10. PAYABLE TO RELATED PARTIES (Details) (USD $)	Nov. 30, 2013	Nov. 30, 2012
Payable to related parties	$2,251,402	$1,617,999
Michel G. Laporte (stockholder and Director)	'	'
Payable to related parties	719,230	172,389
World Asset Management Inc. (stockholder)	'	'
Payable to related parties	1,495,477	1,396,277
Soft Diffusion SA	'	'
Payable to related parties	'	49,333
Other Loan	'	'
Payable to related parties	$36,695	'

11_INCOME_TAXES_Details

11. INCOME TAXES (Details) (USD $)	12 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Income Taxes Details	'	'
Loss before income taxes	($5,651,665)	($3,966,765)
Expected income tax recovery	-1,978,080	-1,388,368
Non-deductible expenses	74,570	220,364
Difference in foreign tax rates, changes in tax rate, foreign exchange impact on translation of tax base and other adjustments	558,030	87,315
Increase in valuation allowance	$1,345,480	$1,080,689

11_INCOME_TAXES_Details_1

11. INCOME TAXES (Details 1) (USD $)	Nov. 30, 2013	Nov. 30, 2012
Deferred income tax assets	'	'
Non-capital losses carried forward	$4,024,820	$2,453,326
Less: allocated against deferred tax liabilities	-631,390	-405,383
Less: valuation allowance	-3,393,430	-2,047,943
Deferred income tax assets	0	0
Deferred tax liabilities	'	'
Property, plant and equipment and intangible assets	631,390	405,383
Less: offset by deferred income tax assets	-631,390	-405,383
Deferred income tax liabilities	$0	$0

12_STOCKHOLDERS_EQUITY_Details

12. STOCKHOLDERS' EQUITY (Details) (USD $)	12 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Stockholders Equity Tables	'	'
Beginning Balance, Shares	6,553,169	5,734,447
Issuance for cash, shares	25,000	258,722
Issuance for cash, price per share	$2.08	$7.67
October 2012 b IPO issuance, shares	'	560,000
October 2012 b IPO issuance, price per share	'	$5
February 2013 Private Placement, shares	425,000	'
February 2013 Private Placement, price per share	$4	'
August 2013 Private Placement, shares	28,248	'
August 2013 Private Placement, price per share	$1.77	'
November 2013 Private Placement, shares	200,000	'
November 2013 Private Placement, price per share	$2	'
Ending Balance, Shares	7,231,417	6,553,169

12_STOCKHOLDERS_EQUITY_Details1

12. STOCKHOLDERS' EQUITY (Details 1) (USD $)	12 Months Ended
	Nov. 30, 2013
Stockholders Equity Tables	'
Preferred Stock, Beginning	0
Series A-1 Private Placement, shares	138,654
Series A-1 Private Placement, price per share	$2.38
Series A-2 Private Placement, shares	122,128
Series A-2 Private Placement, price per share	$2.40
Preferred Stock, Ending	260,782

13_STOCKBASED_COMPENSATION_Det

13. STOCK-BASED COMPENSATION (Details) (USD $)	12 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Stock-Based Compensation Tables	'	'
Exercise price ($)	$7.67	$7.67
Risk-free interest rate, minimum	'	1.92%
Risk-free interest rate, maximum	1.59%	2.08%
Expected term (Years)	'10 years	'10 years
Expected volatility	100.00%	100.00%
Expected dividend yield	0.00%	0.00%
Fair value of option ($), minimum	$1.83	$6.86
Fair value of option ($), maximum	'	$6.90
Expected forfeiture rate	0.00%	0.00%

13_STOCKBASED_COMPENSATION_Det1

13. STOCK-BASED COMPENSATION (Details 1)	12 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Stock-Based Compensation Tables	'	'
Options Outstanding, Beginning	383,310	338,983
Granted	10,000	44,327
Exercised	'	'
Cancelled/forfeited	-27,379	'
Options Outstanding, Ending	365,931	383,310

13_STOCKBASED_COMPENSATION_Det2

13. STOCK-BASED COMPENSATION (Details 2) (USD $)	12 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Exercise price ($)	$7.67	$7.67
Risk-free interest rate, minimum	'	1.92%
Risk-free interest rate, maximum	1.59%	2.08%
Expected term (Years)	'10 years	'10 years
Expected volatility	100.00%	100.00%
Expected dividend yield	0.00%	0.00%
Fair value of option ($), minimum	$1.83	$6.86
Fair value of option ($), maximum	'	$6.90
Expected forfeiture rate	0.00%	0.00%
Stock Option Plan	'	'
Exercise price ($)	$3.94	'
Risk-free interest rate, minimum	0.78%	'
Expected term (Years)	'5 years	'
Expected volatility	100.00%	'
Expected dividend yield	0.00%	'
Fair value of option ($), minimum	$2.93	'

13_STOCKBASED_COMPENSATION_Det3

13. STOCK-BASED COMPENSATION (Details 3)	12 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Options Outstanding, Beginning	383,310	338,983
Granted	10,000	44,327
Exercised	'	'
Cancelled/forfeited	-27,379	'
Options Outstanding, Ending	365,931	383,310
Number of Options	'	'
Granted	100,000	'
Exercised	'	'
Cancelled/forfeited	'	'

15_COMMITMENTS_Details

15. COMMITMENTS (Details) (USD $)	Nov. 30, 2013
Mississauga Facility	'
2014	$139,110
2015	139,110
2016	139,110
2017	139,110
2018	11,593
Sombra Facility	'
2014	372,720
2015	369,845
2016	365,820
2017	321,815
2018	$147,250

15_COMMITMENTS_Details_1

15. COMMITMENTS (Details 1)	Nov. 30, 2013
Agreement 1	'
Start Date	1-Aug-13
End Date	31-Jul-18
Term	'60 months
Agreement 2	'
Start Date	1-Apr-13
End Date	31-Mar-18
Term	'60 months
Agreement 3	'
Start Date	1-Jul-13
End Date	30-Jun-18
Term	'60 months
Agreement 4	'
Start Date	1-Dec-11
End Date	30-Nov-16
Term	'60 months
Agreement 5	'
Start Date	1-Jan-12
End Date	31-Dec-16
Term	'60 months
Agreement 6	'
Start Date	1-May-12
End Date	30-Jun-15
Term	'36 months
Agreement 7	'
Start Date	1-May-13
End Date	30-Apr-18
Term	'60 months
Agreement 8	'
Start Date	1-May-13
End Date	30-Apr-18
Term	'60 months

17_SEGMENT_INFORMATION_Details

17. SEGMENT INFORMATION (Details) (USD $)	12 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Revenue	'	'
United States	$7,749,825	$5,678,693
Canada	1,120,112	871,055
Segment Information, Total	$8,869,937	$6,549,748